Form 4: Performant Healthcare CEO's RSU Vesting & Tax Sale

Performant Healthcare CEO Simeon Kohl acquired 20,250 shares from RSU vesting and sold 7,908 shares for tax obligations.

Summary

• Simeon Kohl, Chief Executive Officer and Director of Performant Healthcare Inc. (PHLT), acquired 20,250 shares of common stock through the vesting of Restricted Stock Units (RSUs).
• Concurrently, 7,908 shares were disposed of at a price of $7.61 per share to satisfy tax withholding obligations related to the RSU vesting.
• The RSU award was originally granted on August 13, 2021, and is structured to vest in four equal installments annually.
• Following these transactions, Simeon Kohl's direct beneficial ownership of Performant Healthcare Inc. common stock stands at 563,403 shares.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged schedule for the purchase or sale of equity securities.

Sentiment

Score: 5

Explanation: The filing details a routine, pre-planned insider transaction involving the vesting of Restricted Stock Units and a subsequent sale for tax purposes, which is a neutral event not indicative of significant positive or negative company performance.

Positives

• The acquisition of 20,250 shares through RSU vesting demonstrates the execution of a long-term incentive compensation plan for the CEO.
• The CEO continues to hold a substantial number of shares (563,403), aligning his interests with shareholders.

Negatives

• The disposition of 7,908 shares, even for tax purposes, results in a reduction of the CEO's direct beneficial ownership.

Future Outlook

The Restricted Stock Units are structured to vest in four equal annual installments, indicating future share acquisitions for the reporting person if continuous service is maintained.

Industry Context

NA

Related Party Transactions

• Vesting of Restricted Stock Units granted to CEO Simeon Kohl as part of his compensation package.

Next Steps

• Future vesting installments of the Restricted Stock Units on the anniversaries of the August 13, 2021 grant date, provided continuous service.

Key Dates

Recommendation

This Form 4 details a routine insider transaction involving the vesting of Restricted Stock Units and the subsequent sale of shares to cover tax obligations. Such pre-planned transactions (indicated by the Rule 10b5-1(c) box) are generally not considered significant indicators of future company performance or management's sentiment beyond the initial compensation agreement. The CEO continues to hold a substantial number of shares. Therefore, this filing alone does not provide sufficient new information to warrant a change in investment recommendation; a 'hold' stance is appropriate, pending further fundamental analysis.

Keywords

Performant Healthcare, PHLT, Simeon Kohl, CEO, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, Stock Compensation, Tax Withholding